Cargando…
s-Triazine: A Privileged Structure for Drug Discovery and Bioconjugation
This review provides an overview of the broad applicability of s-triazine. Our many years working with this intriguing moiety allow us to discuss its wide activity spectrum (inhibition against MAO-A and -B, anticancer/antiproliferative and antimicrobial activity, antibacterial activity against MDR c...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914932/ https://www.ncbi.nlm.nih.gov/pubmed/33562072 http://dx.doi.org/10.3390/molecules26040864 |
_version_ | 1783657119427330048 |
---|---|
author | Sharma, Anamika Sheyi, Rotimi de la Torre, Beatriz G. El-Faham, Ayman Albericio, Fernando |
author_facet | Sharma, Anamika Sheyi, Rotimi de la Torre, Beatriz G. El-Faham, Ayman Albericio, Fernando |
author_sort | Sharma, Anamika |
collection | PubMed |
description | This review provides an overview of the broad applicability of s-triazine. Our many years working with this intriguing moiety allow us to discuss its wide activity spectrum (inhibition against MAO-A and -B, anticancer/antiproliferative and antimicrobial activity, antibacterial activity against MDR clinical isolates, antileishmanial agent, and use as drug nano delivery system). Most of the compounds addressed in our studies and those performed by other groups contain only N-substitution. Exploiting the concept of orthogonal chemoselectivity, first described by our group, we have successfully incorporated different nucleophiles in different orders into s-triazine core for application in peptides/proteins at a temperature compatible with biological systems. |
format | Online Article Text |
id | pubmed-7914932 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-79149322021-03-01 s-Triazine: A Privileged Structure for Drug Discovery and Bioconjugation Sharma, Anamika Sheyi, Rotimi de la Torre, Beatriz G. El-Faham, Ayman Albericio, Fernando Molecules Review This review provides an overview of the broad applicability of s-triazine. Our many years working with this intriguing moiety allow us to discuss its wide activity spectrum (inhibition against MAO-A and -B, anticancer/antiproliferative and antimicrobial activity, antibacterial activity against MDR clinical isolates, antileishmanial agent, and use as drug nano delivery system). Most of the compounds addressed in our studies and those performed by other groups contain only N-substitution. Exploiting the concept of orthogonal chemoselectivity, first described by our group, we have successfully incorporated different nucleophiles in different orders into s-triazine core for application in peptides/proteins at a temperature compatible with biological systems. MDPI 2021-02-06 /pmc/articles/PMC7914932/ /pubmed/33562072 http://dx.doi.org/10.3390/molecules26040864 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Sharma, Anamika Sheyi, Rotimi de la Torre, Beatriz G. El-Faham, Ayman Albericio, Fernando s-Triazine: A Privileged Structure for Drug Discovery and Bioconjugation |
title | s-Triazine: A Privileged Structure for Drug Discovery and Bioconjugation |
title_full | s-Triazine: A Privileged Structure for Drug Discovery and Bioconjugation |
title_fullStr | s-Triazine: A Privileged Structure for Drug Discovery and Bioconjugation |
title_full_unstemmed | s-Triazine: A Privileged Structure for Drug Discovery and Bioconjugation |
title_short | s-Triazine: A Privileged Structure for Drug Discovery and Bioconjugation |
title_sort | s-triazine: a privileged structure for drug discovery and bioconjugation |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914932/ https://www.ncbi.nlm.nih.gov/pubmed/33562072 http://dx.doi.org/10.3390/molecules26040864 |
work_keys_str_mv | AT sharmaanamika striazineaprivilegedstructurefordrugdiscoveryandbioconjugation AT sheyirotimi striazineaprivilegedstructurefordrugdiscoveryandbioconjugation AT delatorrebeatrizg striazineaprivilegedstructurefordrugdiscoveryandbioconjugation AT elfahamayman striazineaprivilegedstructurefordrugdiscoveryandbioconjugation AT albericiofernando striazineaprivilegedstructurefordrugdiscoveryandbioconjugation |